Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Neuroblastoma arginine addiction subverts the anticancer immune response.

De Santo C, Mussai F.

Oncoimmunology. 2015 Nov 11;5(2):e1078967. eCollection 2016 Feb.

2.

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

Mussai F, Egan S, Hunter S, Webber H, Fisher J, Wheat R, McConville C, Sbirkov Y, Wheeler K, Bendle G, Petrie K, Anderson J, Chesler L, De Santo C.

Cancer Res. 2015 Aug 1;75(15):3043-53. doi: 10.1158/0008-5472.CAN-14-3443. Epub 2015 Jun 8.

3.
4.

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.

Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF.

Cancer Chemother Pharmacol. 2000;46 Suppl:S67-72.

PMID:
10950151
5.

New immunotherapeutic strategies for the treatment of neuroblastoma.

Croce M, Corrias MV, Rigo V, Ferrini S.

Immunotherapy. 2015;7(3):285-300. doi: 10.2217/imt.14.117. Review.

PMID:
25804480
6.

Red blood cell arginase suppresses Jurkat (T cell) proliferation by depleting arginine.

Bernard A, Kasten M, Meier C, Manning E, Freeman S, Adams W, Chang P, Boulanger B, Kearney P.

Surgery. 2008 Feb;143(2):286-91. doi: 10.1016/j.surg.2007.07.037. Epub 2007 Dec 21.

PMID:
18242346
7.

Arginine availability, arginase, and the immune response.

Bansal V, Ochoa JB.

Curr Opin Clin Nutr Metab Care. 2003 Mar;6(2):223-8. Review.

PMID:
12589193
8.

Arginine depletion as a mechanism for the immune privilege of corneal allografts.

Fu H, Khan A, Coe D, Zaher S, Chai JG, Kropf P, Müller I, Larkin DF, George AJ.

Eur J Immunol. 2011 Oct;41(10):2997-3005. doi: 10.1002/eji.201141683. Epub 2011 Sep 6.

9.

Arginine is essential in reversing prostaglandin E(2) T-cell suppression by hypertonic saline.

Choi SH, Bansal V, Costantini T, Putnam J, Loomis W, Coimbra R.

J Surg Res. 2009 Sep;156(1):83-9. doi: 10.1016/j.jss.2009.03.059. Epub 2009 May 3.

PMID:
19577247
10.

Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.

Stone E, Chantranupong L, Gonzalez C, O'Neal J, Rani M, VanDenBerg C, Georgiou G.

J Control Release. 2012 Feb 28;158(1):171-9. doi: 10.1016/j.jconrel.2011.09.097. Epub 2011 Oct 6.

11.

Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.

Ino Y, Yamazaki-Itoh R, Oguro S, Shimada K, Kosuge T, Zavada J, Kanai Y, Hiraoka N.

PLoS One. 2013;8(2):e55146. doi: 10.1371/journal.pone.0055146. Epub 2013 Feb 12.

12.

Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.

Tate DJ Jr, Vonderhaar DJ, Caldas YA, Metoyer T, Patterson JR 4th, Aviles DH, Zea AH.

J Hematol Oncol. 2008 Sep 25;1:14. doi: 10.1186/1756-8722-1-14.

13.
14.

Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy.

Kropf P, Baud D, Marshall SE, Munder M, Mosley A, Fuentes JM, Bangham CR, Taylor GP, Herath S, Choi BS, Soler G, Teoh T, Modolell M, Müller I.

Eur J Immunol. 2007 Apr;37(4):935-45.

15.

[Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid].

Tang SQ, Huang DS, Wang JW, Zhang XF, Liu LZ, Yu F, Yang G.

Zhonghua Er Ke Za Zhi. 2004 Jul;42(7):486-9. Chinese.

PMID:
15324562
16.

Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients.

Darcy CJ, Minigo G, Piera KA, Davis JS, McNeil YR, Chen Y, Volkheimer AD, Weinberg JB, Anstey NM, Woodberry T.

Crit Care. 2014 Aug 1;18(4):R163. doi: 10.1186/cc14003.

17.

Suppression of T-cell functions by human granulocyte arginase.

Munder M, Schneider H, Luckner C, Giese T, Langhans CD, Fuentes JM, Kropf P, Mueller I, Kolb A, Modolell M, Ho AD.

Blood. 2006 Sep 1;108(5):1627-34. Epub 2006 May 18.

18.

Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.

Rigo V, Corrias MV, Orengo AM, Brizzolara A, Emionite L, Fenoglio D, Filaci G, Croce M, Ferrini S.

Cancer Immunol Immunother. 2014 May;63(5):501-11. doi: 10.1007/s00262-014-1536-9. Epub 2014 Mar 20.

PMID:
24647609
19.

The arginine-arginase balance in asthma and lung inflammation.

Zimmermann N, Rothenberg ME.

Eur J Pharmacol. 2006 Mar 8;533(1-3):253-62. Epub 2006 Feb 3. Review.

PMID:
16458291
20.

Supplemental Content

Support Center